This core will perform two interrelated functions. It will train physicians who have completed their neurology residencies in both the evaluation and management of patients with Parkinson's disease and other movement disorders and in scientific techniques applicable to the study of Parkinson's disease pathophysiology. It will also establish a clinical core that will support the clinical (project #2) and experimental neuropathological (projects #1 and #3) research studies proposed in this center as well as provides a source of well characterized Parkinson's disease patients for research projects that are not directly part of this center. To accomplish this we will: 1) Examine, diagnose, and enroll in a PD Patient Registry men and women with PD and related parkinsonian syndromes, and healthy control subjects who are matched to the patients with respect to age, gender, and socio- economic status; 2) Characterize the neurological, functional, and neuropsychological features of PD in order to secure the clinical diagnosis and permit correlations between antemortem features of PD and postmortem findings; 3) Refer these carefully evaluated PD patients, and control subjects, to the specific clinical research projects described in the grant (project #2, Dr. Breakefield, PI) and to funded projects outside of the formal center; 4) To obtain brain donations from subjects enrolled in the PD Patient Registry; to process, diagnose and store each brain received; and to submit brain tissue to project #1 (Dr. Hyman, PI) and project #3 (Dr. Penny, PI) and to funded projects outside of the formal center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS038372-02
Application #
6219193
Study Section
Project Start
1999-09-01
Project End
2000-08-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Caraveo, Gabriela; Soste, Martin; Cappelleti, Valentina et al. (2017) FKBP12 contributes to ?-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome. Proc Natl Acad Sci U S A 114:E11313-E11322
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80
Nuytemans, Karen; Inchausti, Vanessa; Beecham, Gary W et al. (2014) Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Mov Disord 29:827-30
Hernandez, Ledia F; Kubota, Yasuo; Hu, Dan et al. (2013) Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons. J Neurosci 33:4782-95
Lemaire, Nuné; Hernandez, Ledia F; Hu, Dan et al. (2012) Effects of dopamine depletion on LFP oscillations in striatum are task- and learning-dependent and selectively reversed by L-DOPA. Proc Natl Acad Sci U S A 109:18126-31
Tardiff, Daniel F; Tucci, Michelle L; Caldwell, Kim A et al. (2012) Different 8-hydroxyquinolines protect models of TDP-43 protein, ?-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem 287:4107-20
Klucken, Jochen; Poehler, Anne-Maria; Ebrahimi-Fakhari, Darius et al. (2012) Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 8:754-66
Lin, Michael T; Cantuti-Castelvetri, Ippolita; Zheng, Kangni et al. (2012) Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol 71:850-4
Unni, Vivek K; Ebrahimi-Fakhari, Darius; Vanderburg, Charles R et al. (2011) Studying protein degradation pathways in vivo using a cranial window-based approach. Methods 53:194-200
Ticozzi, Nicola; LeClerc, Ashley Lyn; van Blitterswijk, Marka et al. (2011) Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiol Aging 32:2096-9

Showing the most recent 10 out of 87 publications